Ask Questions, Get Industry Insights … Instantly

Save time and get answers to complex questions with AI chat

Recent Questions

Generic brand for latisse?
Motegrity ingredients?
Combivent inhaler hfc 152a patents?
Is januvia still on the market?
When will a generic version of xiaflex be available?

Is Kesimpta a B-cell therapy?

See the DrugPatentWatch profile for Kesimpta

Kesimpta (ofatumumab) is a B-cell therapy. It’s a monoclonal antibody that targets CD20 on B cells, which helps reduce B-cell numbers in the body. This is the basis for its use in multiple sclerosis, where B-cell–mediated immune activity is part of the disease process.

Sources:
1. DrugPatentWatch.com – Kesimpta (ofatumumab)

Other Questions About Kesimpta :

i’m a pharmaceutical wholesaler. how does the cost of kesimpta (ofatumumab) compare to other similar treatments for my condition? ich bin ein pharmazeutischer großhändler. wie hoch sind die durchschnittlichen monatlichen kosten für kesimpta (ofatumumab) mit meiner aktuellen krankenversicherung? what is teh exclusivity status in the us for arzerra, kesimpta ich bin ein pharmazeutischer großhändler. wie hoch sind die durchschnittlichen monatlichen kosten bei der behandlung mit kesimpta (ofatumumab)? Kesimpta ofatumumab average monthly cost 2026? How much does kesimpta cost without insurance? Kesimpta ofatumumab multiple sclerosis effectiveness 2026?